Mapping SARS-CoV-2 antigenic relationships and serological responses

绘制SARS-CoV-2抗原关系图和血清学反应图谱

阅读:12
作者:Samuel H Wilks # ,Barbara Mühlemann # ,Xiaoying Shen # ,Sina Türeli ,Eric B LeGresley ,Antonia Netzl ,Miguela A Caniza ,Jesus N Chacaltana-Huarcaya ,Victor M Corman ,Xiaoju Daniell ,Michael B Datto ,Fatimah S Dawood ,Thomas N Denny ,Christian Drosten ,Ron A M Fouchier ,Patricia J Garcia ,Peter J Halfmann ,Agatha Jassem ,Lara M Jeworowski ,Terry C Jones ,Yoshihiro Kawaoka ,Florian Krammer ,Charlene McDanal ,Rolando Pajon ,Viviana Simon ,Melissa S Stockwell ,Haili Tang ,Harm van Bakel ,Vic Veguilla ,Richard Webby ,David C Montefiori ,Derek J Smith

Abstract

During the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, multiple variants escaping preexisting immunity emerged, causing reinfections of previously exposed individuals. Here, we used antigenic cartography to analyze patterns of cross-reactivity among 21 variants and 15 groups of human sera obtained after primary infection with 10 different variants or after messenger RNA (mRNA)-1273 or mRNA-1273.351 vaccination. We found antigenic differences among pre-Omicron variants caused by substitutions at spike-protein positions 417, 452, 484, and 501. Quantifying changes in response breadth over time and with additional vaccine doses, our results show the largest increase between 4 weeks and >3 months after a second dose. We found changes in immunodominance of different spike regions, depending on the variant an individual was first exposed to, with implications for variant risk assessment and vaccine-strain selection.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。